CUSIP 46489V302COM NEWCATXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
114 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 4.56M | $12.54M | +193.4K | Added |
| 2 | Morgan Stanley | 4.47M | $12.30M | +1.71M | Added |
| 3 | Vanguard Group Inc | 3.49M | $9.60M | +52.8K | Added |
| 4 | Avidity Partners Management LP | 3.21M | $8.83M |
| Added |
| 5 | Opaleye Management Inc. | 1.18M | $4.99M | +1.18M | New |
| 6 | Nicholson Wealth Management Group, LLC | 1.62M | $4.45M | −300 | Reduced |
| 7 | Geode Capital Management, LLC | 1.41M | $3.89M | −18.0K | Reduced |
| 8 | Millennium Management LLC | 1.41M | $3.87M | −1.15M | Reduced |
| 9 | Nuveen, LLC | 1.27M | $3.50M | −34.6K | Reduced |
| 10 | Two Sigma Investments, LP | 1.20M | $3.30M | +679.0K | Added |
See every fund holding Perspective Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders